On Jan. 30, 2023, ASTHO released a statement commending the FDA on a new proposal to conduct individual risk assessments for blood donors, a policy that reflects the best available science while not ...
On Oct. 4, 2023, ASTHO, CDC, the Center for Law and Social Policy, and Mental Health America released a framework for public health leaders with effective strategies to improve mental health and ...
On April 12, 2023, ASTHO released a statement applauding the Office of National Drug Control Policy’s announcement designating fentanyl adulterated or associated with xylazine as an emerging drug ...
On March 23, 2023, ASTHO President Anne Zink testified before the U.S. House of Representatives Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.
On Jan. 23, 2023, ASTHO announced it has been awarded funding from the FDA to advance retail food safety initiatives and reduce food-borne illness.
On Jan. 30, 2023, ASTHO released a statement commending the FDA on a new proposal to conduct individual risk assessments for blood donors, a policy that reflects the best available science while not ...
ASTHO Statement on President’s FY24 Budget Proposal ASTHO Statement on President Biden’s FY24 Budget Proposal ARLINGTON, VA—Michael Fraser, PhD, chief executive officer of the Association of State ...
On March 15, 2023, ASTHO announced a jointly-authored article on state and territorial emergency powers since the COVID-19 pandemic has been published in Journal of Emergency Management.
On April 11, 2023, ASTHO and NCSD issued a joint statement addressing rising cases of syphilis and congenital syphilis in the United States.
On March 22, 2023, ASTHO released a statement on EPA's newly-proposed drinking water rule for six PFAS substances.